Cell Signaling Technology

CDK6 (D4S8S) Rabbit Monoclonal Antibody

#13331 · western blot · $152,351

68
Evidence Score · Well-Established
Used by 753 independent labs across 813 papers. How we score this →
100
Citing papers
3.5k
Combined citations
Supplier page Find this product

Research areas

Cancer-related Molecular Pathways15Protein Degradation and Inhibitors10Ubiquitin and proteasome pathways9Advanced Breast Cancer Therapies8Prion Diseases and Protein Misfolding7PI3K/AKT/mTOR signaling in cancer7interferon and immune responses6Cancer Mechanisms and Therapy5

Papers citing this product

1
Combination of eribulin plus AKT inhibitor evokes synergistic cytotoxicity in soft tissue sarcoma cells
Scientific Reports·2019·155 cit.·DOI
2
Mitochondrial calpain-1 activates NLRP3 inflammasome by cleaving ATP5A1 and inducing mitochondrial ROS in CVB3-induced myocarditis
Basic Research in Cardiology·2022·138 cit.·DOI
3
Mycobacterium tuberculosis Inhibits RAB7 Recruitment to Selectively Modulate Autophagy Flux in Macrophages
Scientific Reports·2015·121 cit.·DOI
4
ACSL4 promotes hepatocellular carcinoma progression via c-Myc stability mediated by ERK/FBW7/c-Myc axis
Oncogenesis·2020·119 cit.·DOI
5
Triptolide (TPL) Inhibits Global Transcription by Inducing Proteasome-Dependent Degradation of RNA Polymerase II (Pol II)
PLoS ONE·2011·112 cit.·DOI
6
LncRNA NEAT1 facilitates glioma progression via stabilizing PGK1
Journal of Translational Medicine·2022·91 cit.·DOI
7
Inhibition of PI3K/AKT signaling via ROS regulation is involved in Rhein-induced apoptosis and enhancement of oxaliplatin sensitivity in pancreatic cancer cells
International Journal of Biological Sciences·2021·90 cit.·DOI
8
Dinaciclib, a cyclin-dependent kinase inhibitor, suppresses cholangiocarcinoma growth by targeting CDK2/5/9
Scientific Reports·2020·89 cit.·DOI
9
Elacestrant (RAD1901) exhibits anti-tumor activity in multiple ER+ breast cancer models resistant to CDK4/6 inhibitors
Breast Cancer Research·2019·77 cit.·DOI
10
Targeting GRP78-dependent AR-V7 protein degradation overcomes castration-resistance in prostate cancer therapy
Theranostics·2020·74 cit.·DOI

Similar products

ProductVendorEvidencePricePapers
CDK6 Recombinant Rabbit Monoclonal AntibodyRabbitThermo Fisher Scientific68—200
CDK6 Recombinant monoclonal antibodyRabbitProteintech68$449200
Cdk6 Antibody (8G3)RabbitNovus68—200
Cdk6 Antibody (0O6X7)RabbitNovus68—200
Cdk6 Antibody (S03-2G5)RabbitNovus68—200
Cdk6 Antibody [DyLight 405]RabbitNovus68—200
Cdk6 Antibody [DyLight 350]RabbitNovus68—200
CDK6 (DCS83) Mouse Monoclonal AntibodyMouseCell Signaling Technology68$147,345100
CDK6 (E3E3Q) Rabbit Monoclonal Antibody (BSA and Azide Free)RabbitCell Signaling Technology68$86532
CDK6 (E3E3Q) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology68$189,41532
CDK6 (D4S8S) Rabbit Monoclonal Antibody (BSA and Azide Free)RabbitCell Signaling Technology68$8652
CDK6 (DCS83) Mouse Monoclonal Antibody (BSA and Azide Free)MouseCell Signaling Technology68$865—

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.